Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Edenberg HJ, Kranzler HR (2005). The contribution of genetics to addiction therapy approaches. Pharmacol Ther 108: 86–93.
Koob G, Kreek MJ (2007). Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 164: 1149–1159.
Park HH, Lo YC, Lin SC, Wang L, Yang JK, Wu H (2007). The death domain superfamily in intracellular signaling of apoptosis and inflammation. Annu Rev Immunol 25: 561–586.
Renthal W, Nestler EJ (2008). Epigenetic mechanisms in drug addiction. Trends Mol Med 14: 341–350.
Rogers RD, Robbins TW (2001). Investigating the neurocognitive deficits associated with chronic drug misuse. Curr Opin Neurobiol 11: 250–257.
Shippenberg TS, Zapata A, Chefer VI (2007). Dynorphin and the pathophysiology of drug addiction. Pharmacol Ther 116: 306–321.
Author information
Authors and Affiliations
Corresponding author
Additional information
DISCLOSURE/CONFLICT OF INTEREST
The author declares no conflict of interest.
Rights and permissions
About this article
Cite this article
Kalivas, P. Perspective: The Manifest Destiny of Cocaine Research. Neuropsychopharmacol 34, 1089–1090 (2009). https://doi.org/10.1038/npp.2009.9
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/npp.2009.9